Molecular epidemiology of COVID-19 in Oman: A molecular and surveillance study for the early transmission of COVID-19 in the country

被引:14
作者
Al-Mahruqi, Samira [1 ]
Al-Wahaibi, Adil [1 ]
Khan, Abdul Latif [2 ]
Al-Jardani, Amina [1 ]
Asaf, Sajjad [2 ]
Alkindi, Hanan [1 ]
Al-Kharusi, Samiha [1 ]
Al-Rawahi, Ahmed N. [2 ]
Al-Rawahi, Ahmed [2 ]
Al-Salmani, Majid [2 ]
Al-Shukri, Intisar [1 ]
Al-Busaidi, Aisha [1 ]
Al-Abri, Seif Salem [1 ]
Al-Harrasi, Ahmed [2 ]
机构
[1] Minist Hlth, Directorate Gen Dis Surveillance & Control, POB 393,PC 100, Muscat, Oman
[2] Univ Nizwa, Nat & Med Sci Res Ctr, POB 33,PC 616, Nizwa, Oman
关键词
SARS-CoV-2; COVID-19; epidemiology; Phylogenomic analysis; Clade; Mutation; Oman;
D O I
10.1016/j.ijid.2020.12.049
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been proven to be lethal to human health, which affects almost every corner of the world. The objectives of this study were to add context to the global data and international genomic consortiums, and to give insight into the efficiency of the contact tracing system in Oman. Methods: We combined epidemiological data and whole-genome sequence data from 94 samples of SARS-CoV-2 in Oman to understand the origins, genetic variation, and transmissibility. The whole-genome size of sequence data was obtained through a customized SARS-COV-2 research panel. Amplifier methods ranged from 26 Kbp to 30 Kbp and were submitted to GISAID. Findings: The study found that P323L (94.7%) is the most common mutation, followed by D614G (92.6%) Spike protein mutation. A unique mutation, I280V, was first reported in Oman and was associated with a rare lineage, B.1.113 (10.6%). In addition, the study revealed a good agreement between genetic and epidemiological data. Interpretation: Oman's robust surveillance system was very efficient in guiding the outbreak investigation processes in the country, the study illustrates the future importance of molecular epidemiology in leading the national response to outbreaks and pandemics. (c) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:139 / 149
页数:11
相关论文
共 23 条
  • [1] Multiple early introductions of SARS-CoV-2 into a global travel hub in the Middle East
    Abou Tayoun, Ahmad
    Loney, Tom
    Khansaheb, Hamda
    Ramaswamy, Sathishkumar
    Harilal, Divinlal
    Deesi, Zulfa Omar
    Varghese, Rupa Murthy
    Al Suwaidi, Hanan
    Alkhajeh, Abdulmajeed
    AlDabal, Laila Mohamed
    Uddin, Mohammed
    Hamoudi, Rifat
    Halwani, Rabih
    Senok, Abiola
    Hamid, Qutayba
    Nowotny, Norbert
    Alsheikh-Ali, Alawi
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] COVID-19 epidemic monitoring after non-pharmaceutical interventions: The use of time-varying reproduction number in a country with a large migrant population
    Al Wahaibi, Adil
    Al Manji, Abdullah
    Al Maani, Amal
    Al Rawahi, Bader
    Al Harthy, Khalid
    Alyaquobi, Fatma
    Al-Jardani, Amina
    Petersen, Eskild
    Al Abri, Seif
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 99 : 466 - 472
  • [3] Alandijany TA, 2020, J INFECT PUBLIC HEAL, V13, P839, DOI [10.1016/j.jiph.2020.05.020, 10.1016/j.jiph.2020.50.020]
  • [4] Bakri F, 2020, TEMPORAL INCREASE D6, DOI [10.1101/2020.08.24.20176792, DOI 10.1101/2020.08.24.20176792]
  • [5] COVID-19 Genomics UK Consortium, 2020, COV GLUE ENABLED DAT
  • [6] COVID-19 Genomics UK Consortium, 2020, REPORT 9 25 JUNE 202
  • [7] FEHR AR, 2015, METHOD MOL BIOL, V1282, DOI DOI 10.1007/978-1-4939-2438-7_1
  • [8] Tracking virus outbreaks in the twenty-first century
    Grubaugh, Nathan D.
    Ladner, Jason T.
    Lemey, Philippe
    Pybus, Oliver G.
    Rambaut, Andrew
    Holmes, Edward C.
    Andersen, Kristian G.
    [J]. NATURE MICROBIOLOGY, 2019, 4 (01) : 10 - 19
  • [9] Hodcroft EB, 2021, medRxiv, DOI [10.1101/2020.10.25.20219063, 10.1101/2020.10.25.20219063, DOI 10.1101/2020.10.25.20219063]
  • [10] Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60